SPC Logo

Mepact 4 mg powder for suspension for infusion

Last Updated on eMC 19-Dec-2013 View document  | Takeda UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19-Dec-2013 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 4 - how to report a side effect
  • Improved presentation of PIL
  • Removal of black triangle

Updated on 07-Oct-2013 and displayed until 19-Dec-2013

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder

Updated on 14-Jun-2013 and displayed until 07-Oct-2013

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Updated on 05-Apr-2013 and displayed until 14-Jun-2013

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 05-Sep-2012 and displayed until 05-Apr-2013

Reasons for adding or updating:

  • Change to side-effects

Updated on 11-May-2010 and displayed until 05-Sep-2012

Reasons for adding or updating:

  • Change to MA holder contact details

Updated on 03-Feb-2010 and displayed until 11-May-2010

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 03-Feb-2010 and displayed until 03-Feb-2010

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Takeda UK Ltd

Company image
Address

Building 3, Glory Park Avenue, Wooburn Green, High Wycombe, HP10 0DF

Fax

+44 (0)1628 526 615

Medical Information e-mail
Telephone

+44 (0)1628 537 900

Medical Information Direct Line

+44 (0)1628 537 900

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

mifamurtide

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.